Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
780 | 2990 | 49.4 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1018 | 9825 | CD1D//GAMMA DELTA T CELLS//ALPHA GALACTOSYLCERAMIDE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD1D | Author keyword | 433 | 83% | 8% | 246 |
2 | ALPHA GALACTOSYLCERAMIDE | Author keyword | 305 | 84% | 6% | 167 |
3 | NKT CELLS | Author keyword | 183 | 57% | 7% | 219 |
4 | CD1 | Author keyword | 145 | 65% | 5% | 138 |
5 | NKT CELL | Author keyword | 128 | 69% | 4% | 111 |
6 | NATURAL KILLER T CELLS | Author keyword | 121 | 59% | 5% | 135 |
7 | INKT CELLS | Author keyword | 110 | 75% | 3% | 79 |
8 | ALPHA GALCER | Author keyword | 110 | 90% | 2% | 47 |
9 | KRN7000 | Author keyword | 58 | 86% | 1% | 30 |
10 | NATURAL KILLER T CELL | Author keyword | 54 | 59% | 2% | 60 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD1D | 433 | 83% | 8% | 246 | Search CD1D | Search CD1D |
2 | ALPHA GALACTOSYLCERAMIDE | 305 | 84% | 6% | 167 | Search ALPHA+GALACTOSYLCERAMIDE | Search ALPHA+GALACTOSYLCERAMIDE |
3 | NKT CELLS | 183 | 57% | 7% | 219 | Search NKT+CELLS | Search NKT+CELLS |
4 | CD1 | 145 | 65% | 5% | 138 | Search CD1 | Search CD1 |
5 | NKT CELL | 128 | 69% | 4% | 111 | Search NKT+CELL | Search NKT+CELL |
6 | NATURAL KILLER T CELLS | 121 | 59% | 5% | 135 | Search NATURAL+KILLER+T+CELLS | Search NATURAL+KILLER+T+CELLS |
7 | INKT CELLS | 110 | 75% | 3% | 79 | Search INKT+CELLS | Search INKT+CELLS |
8 | ALPHA GALCER | 110 | 90% | 2% | 47 | Search ALPHA+GALCER | Search ALPHA+GALCER |
9 | KRN7000 | 58 | 86% | 1% | 30 | Search KRN7000 | Search KRN7000 |
10 | NATURAL KILLER T CELL | 54 | 59% | 2% | 60 | Search NATURAL+KILLER+T+CELL | Search NATURAL+KILLER+T+CELL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KILLER T CELLS | 889 | 64% | 29% | 867 |
2 | ALPHA GALACTOSYLCERAMIDE | 809 | 76% | 19% | 569 |
3 | NKT CELLS | 489 | 47% | 26% | 780 |
4 | MOUSE CD1 | 375 | 90% | 6% | 165 |
5 | VALPHA14 NKT CELLS | 306 | 79% | 7% | 197 |
6 | LIGAND ALPHA GALACTOSYLCERAMIDE | 256 | 95% | 3% | 83 |
7 | CD1D | 188 | 77% | 4% | 129 |
8 | CD1D TETRAMERS | 169 | 82% | 3% | 99 |
9 | ANTIGEN PRESENTING MOLECULES | 134 | 80% | 3% | 82 |
10 | MOUSE CD1D | 125 | 97% | 1% | 35 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The biology of NKT cells | 2007 | 961 | 233 | 84% |
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions | 2013 | 118 | 225 | 89% |
Raising the NKT cell family | 2010 | 218 | 128 | 83% |
Presumed guilty: natural killer T cell defects and human disease | 2011 | 131 | 104 | 92% |
Harnessing invariant NKT cells in vaccination strategies | 2009 | 168 | 124 | 92% |
Toward an understanding of NKT cell biology: Progress and paradoxes | 2005 | 630 | 147 | 93% |
Recognition of CD1d-restricted antigens by natural killer T cells | 2012 | 86 | 127 | 93% |
CD1: Antigen presentation and T cell function | 2004 | 643 | 416 | 83% |
Biology of CD1-and MR1-Restricted T Cells | 2014 | 21 | 360 | 88% |
MR1 presentation of vitamin B-based metabolite ligands | 2015 | 3 | 26 | 92% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEV IMMUNOL UNIT | 23 | 100% | 0.3% | 10 |
2 | UNIT CELLULAR IMMUNOTHER Y | 19 | 64% | 0.6% | 18 |
3 | DEV IMMUNOL | 15 | 15% | 3.0% | 90 |
4 | HIV MALARIA VACCINE PROGRAM | 10 | 50% | 0.5% | 14 |
5 | BIOCHEM MOL BIOL BIOMED SCI | 8 | 70% | 0.2% | 7 |
6 | IMMUNE REGULATTSURUMI KU | 8 | 100% | 0.2% | 5 |
7 | MOL IMMUNOL INFLAMMAT | 7 | 27% | 0.7% | 22 |
8 | EXPT IMMUNOL UNIT | 7 | 28% | 0.7% | 20 |
9 | GLYCOSPHINGOLIPID SYNTH GRP | 6 | 48% | 0.3% | 10 |
10 | COMM IMMUNOL | 6 | 10% | 1.8% | 55 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184596 | EXTRATHYMIC T CELLS//EXTRATHYMIC T CELL//INTERMEDIATE TCR CELL |
2 | 0.0000047878 | JASPINE B//PACHASTRISSAMINE//CEREBROSIDE |
3 | 0.0000044568 | XLP//2B4//X LINKED LYMPHOPROLIFERATIVE DISEASE |
4 | 0.0000039474 | D GALACTOSAMINE//BICYCLOL//CON A INDUCED HEPATITIS |
5 | 0.0000035244 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
6 | 0.0000034338 | T CELL DEVELOPMENT//PRE T CELL RECEPTOR//THYMIC SELECTION |
7 | 0.0000034187 | GAMMA DELTA T CELLS//GAMMA DELTA T CELL//PHOSPHOANTIGEN |
8 | 0.0000033003 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |
9 | 0.0000027774 | RHEUMATOID SYNOVIAL MEMBRANE//ANTITUMORAL IMMUNE RESPONSE//ANTITUMORAL IMMUNOTHERAPY |
10 | 0.0000023196 | CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CYTOKINE INDUCED KILLER CELL |